ADAGIO misses a beat?
Kieburtz
Karl
K
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012107:Research Design; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D007980:Levodopa